GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...
Quick access to key HIV drug hinges on waiver of local clinical trials: Experts
Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three ...
Biopharma firm Gilead announces lenacapavir licensing for HIV treatment
International AIDS Society, an association of HIV/AIDS professionals, applauded moves by Gilead Sciences, a biopharma company ...
manilatimes7h
Gilead licenses anti-HIV drug to generic drugmakers
United States pharmaceutical giant Gilead said on Wednesday it had signed licensing deals with six generic drugmakers to ...
BioSpace7h
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...
Gilead inks pact with six generic drugmakers on long-acting HIV injectable, even as civil society oppose patent application
Six drugmakers sign agreements with Gilead Sciences to produce generic lenacapavir, a long-acting HIV drug, amid patent ...
IAS Calls For Global Access As Gilead Announces Lenacapavir Licensing
3 October 2024 (Geneva, Switzerland) – IAS – the International AIDS Society – applauds moves by Gilead Sciences to make generic injectable lenacapavir for HIV prevention widely available, but cautions ...
India Today9h
Indian pharma firms sign deal to produce, sell generic HIV drug lenacapavir
Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements ...
Daily9h
Gilead Sciences inks pacts with Dr Reddy's Labs, Emcure, Hetero and 3 others for HIV drug Lenacapavir
Gilead Sciences, Inc. has announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six ...
STAT9h
Dockworker strike puts drug supplies at risk
How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...
Moneylife10h
Nifty, Sensex Wilt Under Geopolitical Tensions - Thursday Closing Report
On Thursday, 1120 stocks advanced, 2864 declined and 92 remained unchanged, with an advance decline ratio 0.39 on the Bombay Stock Exchange (BSE), indicating negative closing of stocks in broader ...